RBC and Bleeding Disorders Flashcards
Defects in membrane skeleton (spectrin, ankyrin, band 3, band 4.2) – less deformable red cells
EXTRAVASCULAR
increased MCHC
spherocytes
OSMOTIC FRAGILITY TESTING
Splenectomy
HEREDITARY SPHEROCYTOSIS
AD
Defects in membrane skeleton (spectrin, ankyrin, band 3, band 4.2) – less deformable red cells
EXTRAVASCULAR
increased MCHC
spherocytes
OSMOTIC FRAGILITY TESTING
HEREDITARY SPHEROCYTOSIS
AD
Splenectomy
Decreased NADPH needed for glutathione reduction – red cells vulnerable to lysis with OXIDATIVE STRESS
INTRAVASCULAR
EXTRAVASCULAR
HEINZ BODIES
BITE CELLS (Degmacytes)
Protective against malaria
G6PD DEFICIENCY
X-linked recessive
NBS
Aversion to triggers
Mutation on the 6th codon of the B-globin gene
(GLU –> VAL)
Red cells become SICKLED when exposed to low pH and decreased oxygen tension
SICKLE CELLS (drepanocytes)
TARGET CELLS (codocytes)
HOWELL JOLLY BODIES - nuclear remnant in asplenic patients
Protective against malaria
SICKLE CELL DISEASE
AR
Hgb electrophoresis
Hydroxyurea
Abnormalities in RNA splicing or decreased transcription
6-9 mos of age
HbF –> HbA synthesis
BETA THALASSEMIAS
B thalassemia major (COOLEY ANEMIA) - HbF (a2y2)
B thalassemia minor - HbA2
Deletions
symptoms appear at BIRTH
newborns - HgB barts (y4)
older children and adults - HbH (B4)
ALPHA THALASSEMIAS
PIGA mutations –> decreased complement regulatory proteins
CD55 (decay accelerating factor)
CD59 - most important
C8 binding protein
INTRINSIC
INTRAVASCULAR
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PIGA)
nocturnal hemoglobinuria
thrombosis - MC disease related death
AML or MDS as sequelae
HSC transplantation
Eculizumab
MC adverse transfusion reaction
temperature of 38 C or 1 C increase from pretransfusion temperature during or within 4 hrs
Febrile Non-Hemolytic Transfusion Reaction (FNHTR)
proinflammatory cytokines produced by donor leukocytes and platelets
antipyretics
avoid using old blood products, use of leukoreduced blood products
MC reaction encountered in PLATELET transfusion
2nd MC reaction encountered in RBC transfusion
Allergic symptoms during or within 2 hrs after transfusion
Allergic Reaction
Clinical and biochemical evidence of hemolysis and serologic evidence of RBC incompatibility during or within 24 hrs after transfusion
MCC - ABO incompatibility
LETHAL
fever - MC manifestation
flank or lower back pain
hemoglobinuria - tea colored urine
positive DAT
Acute Hemolytic Transfusion Reaction
preformed IgM antibodies against donor red cells that fix complement –> complement mediated lysis and intravascular hemolysis
Positive DAT 24 hrs to 28 days after transfusion with either
(+) eluate or newly identified alloantibody
evidence of hemolysis
exposure to non-ABO antigens - COMMON CAUSE
Delayed Hemolytic or Serologic Transfusion Reaction
Acute lung injury during or within 6 hrs after transfusion
fever, hypotension, hypoxemia, radiographic evidence of pulmonary edema
Transfusion Related Acute Lung Injury (TRALI)
antibodies or non-antibody compounds activate neutrophils
Microangiopathic Hemolytic Anemia
Thrombocytopenia
Renal Failure
Fever
Neurologic manifestations
Thrombotic Thrombocytopenic Purpura